
ESMO 2019: Breast and ovarian cancer drug outperforms targeted hormone therapy in some men
A drug used for breast and ovarian cancer is more effective than modern targeted hormone…
A drug used for breast and ovarian cancer is more effective than modern targeted hormone…
Breast cancer medicines may force some cancer cells into ‘sleeper mode’, allowing them to potentially…
Although the genitourinary syndrome of menopause (GSM) is more prevalent in survivors of breast cancer…
Approximately 10-15 percent of breast cancer cases do not respond to treatment with hormone therapy,…
A new study has shown that a standard hormone supplement, used to boost energy levels…